Meetings of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria, 6177 [2022-02291]
Download as PDF
<![CDATA[
Federal Register / Vol. 87, No. 23 / Thursday, February 3, 2022 / Notices
Estimated Total Annual Burden
Hours: 250,200.
Authority: 45 CFR 75.203–75.204 and
45 CFR part 75, Appendix I.
Mary B. Jones,
ACF/OPRE Certifying Officer.
[FR Doc. 2022–02177 Filed 2–2–22; 8:45 am]
BILLING CODE 4184–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Department of Health and
Human Services, Office of the Secretary,
Office of the Assistant Secretary for
Health.
ACTION: Notice.
AGENCY:
As stipulated by the Federal
Advisory Committee Act, the
Department of Health and Human
Services (HHS) is hereby giving notice
that a meeting is scheduled to be held
for the Presidential Advisory Council on
Combating Antibiotic-Resistant Bacteria
(PACCARB). The meeting will be open
to the public via Zoom and
teleconference; a pre-registered public
comment session will be held during
the meeting. Pre-registration is required
for members of the public who wish to
present their comments at the meeting
via Zoom/teleconference. Individuals
who wish to send in their written public
comment should send an email to
CARB@hhs.gov. Registration
information is available on the website
https://www.hhs.gov/paccarb and must
be completed by February 25, 2022 for
the March 2, 2022 Public Meeting.
Additional information about registering
for the meeting and providing public
comment can be obtained at https://
www.hhs.gov/paccarb on the Upcoming
Meetings page.
DATES: The meeting is scheduled to be
held on March 2, 2022, from 10:00 a.m.
to 4:00 p.m. ET (times are tentative and
subject to change). The confirmed times
and agenda items for the meeting will be
posted on the website for the PACCARB
at https://www.hhs.gov/paccarb when
this information becomes available. Preregistration for attending the meeting is
strongly suggested and should be
completed no later than February 25,
2022.
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
Instructions regarding
attending this meeting virtually will be
posted at least one week prior to the
meeting at: https://www.hhs.gov/
paccarb.
VerDate Sep<11>2014
19:04 Feb 02, 2022
Jkt 256001
Jomana Musmar, M.S., Ph.D.,
Designated Federal Officer, Presidential
Advisory Council on Combating
Antibiotic-Resistant Bacteria, Office of
the Assistant Secretary for Health, U.S.
Department of Health and Human
Services, Room L616, Switzer Building,
330 C St. SW, Washington, DC 20024.
Phone: 202–746–1512; Email: CARB@
hhs.gov.
The
Presidential Advisory Council on
Combating Antibiotic-Resistant Bacteria
(PACCARB), established by Executive
Order 13676, is continued by Section
505 of Public Law 116–22, the
Pandemic and All-Hazards
Preparedness and Advancing Innovation
Act of 2019 (PAHPAIA). Activities and
duties of the Advisory Council are
governed by the provisions of the
Federal Advisory Committee Act
(FACA), Public Law 92–463, as
amended (5 U.S.C. App.), which sets
forth standards for the formation and
use of federal advisory committees.
The PACCARB shall advise and
provide information and
recommendations to the Secretary
regarding programs and policies
intended to reduce or combat antibioticresistant bacteria that may present a
public health threat and improve
capabilities to prevent, diagnose,
mitigate, or treat such resistance. The
PACCARB shall function solely for
advisory purposes.
Such advice, information, and
recommendations may be related to
improving: The effectiveness of
antibiotics; research and advanced
research on, and the development of,
improved and innovative methods for
combating or reducing antibiotic
resistance, including new treatments,
rapid point-of-care diagnostics,
alternatives to antibiotics, including
alternatives to animal antibiotics, and
antimicrobial stewardship activities;
surveillance of antibiotic-resistant
bacterial infections, including publicly
available and up-to-date information on
resistance to antibiotics; education for
health care providers and the public
with respect to up-to-date information
on antibiotic resistance and ways to
reduce or combat such resistance to
antibiotics related to humans and
animals; methods to prevent or reduce
the transmission of antibiotic-resistant
bacterial infections; including
stewardship programs; and coordination
with respect to international efforts in
order to inform and advance the United
States capabilities to combat antibiotic
resistance.
SUPPLEMENTARY INFORMATION:
Meetings of the Presidential Advisory
Council on Combating AntibioticResistant Bacteria
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
6177
The March 2, 2022, public meeting
will be dedicated to providing a One
Health retrospective on past novel viral
outbreaks and how they impacted
antimicrobial use, resistance, and
stewardship. The meeting agenda will
be posted on the PACCARB website at
https://www.hhs.gov/paccarb when it has
been finalized. All agenda items are
tentative and subject to change.
Instructions regarding attending the
meeting virtually will be posted at least
one week prior to the meeting at: https://
www.hhs.gov/paccarb.
Members of the public will have the
opportunity to provide comments live
during the March meeting by preregistering online at https://
www.hhs.gov/paccarb. Pre-registration
is required for participation in this
session with limited spots available.
Written public comments can also be
emailed to CARB@hhs.gov by midnight
February 25, 2022, and should be
limited to no more than one page. All
public comments received prior to
February 25, 2022, will be provided to
the Advisory Council members.
Additionally, companies and/or
organizations involved in combating
antibiotic resistance have an
opportunity to present their work to
members of the Advisory Council live
during an Innovation Spotlight. Preregistration is required for participation,
with limited spots available. All
information regarding this session can
also be found online at https://
www.hhs.gov/paccarb.
Dated: January 27, 2022.
Jomana F. Musmar,
Designated Federal Officer, Presidential
Advisory Council on Combating AntibioticResistant Bacteria, Office of the Assistant
Secretary for Health.
[FR Doc. 2022–02291 Filed 2–2–22; 8:45 am]
BILLING CODE 4150–44–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Arthritis, Connective
Tissue and Skin Study Section,
February 17–18, 2022, 9:00 a.m. to 7:00
p.m., which was published in the
Federal Register on January 19, 2022,
FR DOC 2022–00962, 87 FR 2878.
This notice is being amended to
change the meeting date from February
17–18, 2022, 9:00 a.m. to 7:00 p.m. to
February 16–18, 2022, 12:00 p.m. to
7:00 p.m. The meeting place remains the
E:\FR\FM\03FEN1.SGM
03FEN1
]]>Agencies
[Federal Register Volume 87, Number 23 (Thursday, February 3, 2022)]
[Notices]
[Page 6177]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-02291]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Meetings of the Presidential Advisory Council on Combating
Antibiotic-Resistant Bacteria
AGENCY: Department of Health and Human Services, Office of the
Secretary, Office of the Assistant Secretary for Health.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: As stipulated by the Federal Advisory Committee Act, the
Department of Health and Human Services (HHS) is hereby giving notice
that a meeting is scheduled to be held for the Presidential Advisory
Council on Combating Antibiotic-Resistant Bacteria (PACCARB). The
meeting will be open to the public via Zoom and teleconference; a pre-
registered public comment session will be held during the meeting. Pre-
registration is required for members of the public who wish to present
their comments at the meeting via Zoom/teleconference. Individuals who
wish to send in their written public comment should send an email to
[email protected]. Registration information is available on the website
https://www.hhs.gov/paccarb and must be completed by February 25, 2022
for the March 2, 2022 Public Meeting. Additional information about
registering for the meeting and providing public comment can be
obtained at https://www.hhs.gov/paccarb on the Upcoming Meetings page.
DATES: The meeting is scheduled to be held on March 2, 2022, from 10:00
a.m. to 4:00 p.m. ET (times are tentative and subject to change). The
confirmed times and agenda items for the meeting will be posted on the
website for the PACCARB at https://www.hhs.gov/paccarb when this
information becomes available. Pre-registration for attending the
meeting is strongly suggested and should be completed no later than
February 25, 2022.
ADDRESSES: Instructions regarding attending this meeting virtually will
be posted at least one week prior to the meeting at: https://www.hhs.gov/paccarb.
FOR FURTHER INFORMATION CONTACT: Jomana Musmar, M.S., Ph.D., Designated
Federal Officer, Presidential Advisory Council on Combating Antibiotic-
Resistant Bacteria, Office of the Assistant Secretary for Health, U.S.
Department of Health and Human Services, Room L616, Switzer Building,
330 C St. SW, Washington, DC 20024. Phone: 202-746-1512; Email:
[email protected].
SUPPLEMENTARY INFORMATION: The Presidential Advisory Council on
Combating Antibiotic-Resistant Bacteria (PACCARB), established by
Executive Order 13676, is continued by Section 505 of Public Law 116-
22, the Pandemic and All-Hazards Preparedness and Advancing Innovation
Act of 2019 (PAHPAIA). Activities and duties of the Advisory Council
are governed by the provisions of the Federal Advisory Committee Act
(FACA), Public Law 92-463, as amended (5 U.S.C. App.), which sets forth
standards for the formation and use of federal advisory committees.
The PACCARB shall advise and provide information and
recommendations to the Secretary regarding programs and policies
intended to reduce or combat antibiotic-resistant bacteria that may
present a public health threat and improve capabilities to prevent,
diagnose, mitigate, or treat such resistance. The PACCARB shall
function solely for advisory purposes.
Such advice, information, and recommendations may be related to
improving: The effectiveness of antibiotics; research and advanced
research on, and the development of, improved and innovative methods
for combating or reducing antibiotic resistance, including new
treatments, rapid point-of-care diagnostics, alternatives to
antibiotics, including alternatives to animal antibiotics, and
antimicrobial stewardship activities; surveillance of antibiotic-
resistant bacterial infections, including publicly available and up-to-
date information on resistance to antibiotics; education for health
care providers and the public with respect to up-to-date information on
antibiotic resistance and ways to reduce or combat such resistance to
antibiotics related to humans and animals; methods to prevent or reduce
the transmission of antibiotic-resistant bacterial infections;
including stewardship programs; and coordination with respect to
international efforts in order to inform and advance the United States
capabilities to combat antibiotic resistance.
The March 2, 2022, public meeting will be dedicated to providing a
One Health retrospective on past novel viral outbreaks and how they
impacted antimicrobial use, resistance, and stewardship. The meeting
agenda will be posted on the PACCARB website at https://www.hhs.gov/paccarb when it has been finalized. All agenda items are tentative and
subject to change. Instructions regarding attending the meeting
virtually will be posted at least one week prior to the meeting at:
https://www.hhs.gov/paccarb.
Members of the public will have the opportunity to provide comments
live during the March meeting by pre-registering online at https://www.hhs.gov/paccarb. Pre-registration is required for participation in
this session with limited spots available. Written public comments can
also be emailed to [email protected] by midnight February 25, 2022, and
should be limited to no more than one page. All public comments
received prior to February 25, 2022, will be provided to the Advisory
Council members. Additionally, companies and/or organizations involved
in combating antibiotic resistance have an opportunity to present their
work to members of the Advisory Council live during an Innovation
Spotlight. Pre-registration is required for participation, with limited
spots available. All information regarding this session can also be
found online at https://www.hhs.gov/paccarb.
Dated: January 27, 2022.
Jomana F. Musmar,
Designated Federal Officer, Presidential Advisory Council on Combating
Antibiotic-Resistant Bacteria, Office of the Assistant Secretary for
Health.
[FR Doc. 2022-02291 Filed 2-2-22; 8:45 am]
BILLING CODE 4150-44-P
